The resulting inhibition of tumor progression, that was greater than that observed in IL-30KO mice bearing wild type tumors, reveals the consequences of IL-30 targeting in CSCs, which interrupts the IL-30 autocrine and paracrine loops. Here, IL27 is linked to neoplasm.